Company news
Aptamer Group PLC news in 2023
Aptamer Group PLC's news releases, calls and decks from 2023, newest first.
Results of 2023 Annual General Meeting
December 15, 2023
Material Agreement with Genetic Medicines Company
December 14, 2023
Full year results for the 12mths ended 30 Jun 2023
November 9, 2023
Grant of Options and Related Party Transaction
October 9, 2023
Placing and Subscription, PDMR Dealing and TVR
September 19, 2023
Contract wins
August 17, 2023
TR-1
August 15, 2023
Update on Strategic Review and Formal Sale Process
July 31, 2023
Fundraise, Proposed Board Changes, RPT, GM Notice
July 31, 2023
Response to Speculation, Strategic Review, Update
July 26, 2023
Contract Wins
July 7, 2023
Response to Share Price Movement
June 14, 2023
Aptamer & Neuro-Bio to develop Alzheimer’s test
June 14, 2023
Aptamer Group: Directorate Change
May 10, 2023
Total Voting Rights
April 5, 2023
Optimer-Fc launched for immunohistochemistry
March 20, 2023
Notice of Interim Results
March 1, 2023
Appointment of Chief Financial Officer
February 13, 2023
Aptamer Group project with consumer goods company
January 30, 2023
Issue of Equity and Total Voting Rights
January 25, 2023
Aptamer Group signs two substantial new contracts
January 24, 2023
Aptamer Group Appointment of Interim Chief Comm...
January 10, 2023
Issue of shares
January 9, 2023
Calls in 2023
Decks in 2023
- H1 FY2023 Earnings Presentation
Earnings · 16 slides · March 2023